Needham & Company LLC Cuts Earnings Estimates for Teleflex

Teleflex Incorporated (NYSE:TFX) – Equities research analysts at Needham & Company LLC lowered their FY2025 EPS estimates for shares of Teleflex in a report released on Tuesday, January 27th. Needham & Company LLC analyst M. Matson now expects that the medical technology company will post earnings per share of $13.96 for the year, down from their prior forecast of $14.11. Needham & Company LLC currently has a “Buy” rating and a $138.00 price target on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share.

TFX has been the subject of several other reports. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Truist Financial increased their price objective on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research report on Thursday, December 18th. Wells Fargo & Company reduced their target price on shares of Teleflex from $139.00 to $116.00 and set an “equal weight” rating for the company in a research note on Thursday. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a research report on Wednesday, December 17th. Two research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $139.00.

Teleflex Stock Performance

Shares of Teleflex stock opened at $105.45 on Friday. The stock’s fifty day simple moving average is $116.22 and its 200 day simple moving average is $119.63. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $4.66 billion, a PE ratio of -14.35, a PEG ratio of 1.38 and a beta of 0.93. Teleflex has a 12 month low of $100.18 and a 12 month high of $184.58.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The business’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is currently -18.50%.

Institutional Trading of Teleflex

Several institutional investors and hedge funds have recently added to or reduced their stakes in TFX. MassMutual Private Wealth & Trust FSB boosted its position in shares of Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 77 shares during the period. Thompson Investment Management Inc. boosted its holdings in Teleflex by 2.1% in the 2nd quarter. Thompson Investment Management Inc. now owns 4,970 shares of the medical technology company’s stock valued at $588,000 after purchasing an additional 100 shares during the period. Fifth Third Bancorp grew its position in shares of Teleflex by 7.8% during the 3rd quarter. Fifth Third Bancorp now owns 2,083 shares of the medical technology company’s stock worth $255,000 after purchasing an additional 151 shares in the last quarter. Osaic Holdings Inc. increased its holdings in shares of Teleflex by 17.5% during the second quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock worth $148,000 after purchasing an additional 186 shares during the period. Finally, Hantz Financial Services Inc. raised its position in shares of Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after buying an additional 199 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.